Blaze Bioscience

Investors · 1

KE

Keiretsu ForumSan Francisco · $250K – $2M

$108.7M disclosed across 10 rounds · 2013–2024

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

PR

Precision BioSciences13 shared keywordsPrecision BioSciences develops gene-editing medicines using its proprietary ARCUS genome editing platform, which employs sequence-specific nuclease enzymes to insert, remove, or repair DNA in living cells to treat hard-to-treat conditions including rare genetic diseases and hepatitis B (HBV).

CA

Castle Biosciences10 shared keywordsCastle Biosciences develops genomic diagnostic tests that use a patient's molecular biology to inform disease management and treatment decisions. Its tests serve healthcare providers and patients across multiple clinical focus areas to guide diagnosis, treatment, and follow-up care.

PI

Pillar Biosciences10 shared keywordsPillar Biosciences develops kitted next-generation sequencing (NGS) panels and its SLIMamp single-tube library preparation technology for clinical and research laboratories, focused on cancer diagnostics. Its oncoReveal portfolio of RUO and IVD oncology panels covers solid tumors, hematologic cancers, and liquid biopsy, aiming to deliver faster, lower-cost genomic testing for precision medicine.

LI

Life Biosciences9 shared keywordsLongevity company with diversified therapies to extend healthy human lifespan

Companies competing with Blaze Bioscience for the same Google search keywords, organic and paid, via search-intersection analysis.

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.